Loss-Making Cosmos Health Inc. (NASDAQ:COSM) Set To Breakeven

Cosmos Health Inc. (NASDAQ:COSM) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. With the latest financial year loss of US$19m and a trailing-twelve-month loss of US$24m, the US$16m market-cap company amplified its loss by moving further away from its breakeven target. Many investors are wondering about the rate at which Cosmos Health will turn a profit, with the big question being “when will the company breakeven?” In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

According to the 2 industry analysts covering Cosmos Health, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2025, before generating positive profits of US$6.0m in 2026. The company is therefore projected to breakeven around a year from now or less! We calculated the rate at which the company must grow to meet the consensus forecasts predicting breakeven within 12 months. It turns out an average annual growth rate of 72% is expected, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected.

We're not going to go through company-specific developments for Cosmos Health given that this is a high-level summary, but, bear in mind that typically a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

View our latest analysis for Cosmos Health

One thing we would like to bring into light with Cosmos Health is its relatively high level of debt. Typically, debt shouldn’t exceed 40% of your equity, which in Cosmos Health's case is 74%. Note that a higher debt obligation increases the risk in investing in the loss-making company.

Next Steps:

This article is not intended to be a comprehensive analysis on Cosmos Health, so if you are interested in understanding the company at a deeper level, take a look at Cosmos Health's company page on Simply Wall St. We've also compiled a list of important factors you should look at:

1. Valuation: What is Cosmos Health worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Cosmos Health is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Cosmos Health’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.